18 employees
Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.
2022
$12M
from 3 investors over 3 rounds
Vevo Therapeutics raised $12M on December 8, 2022
Investors: General Catalyst, Camford Capital and AIX Ventures